Researchers Take New AI Approach to Analyze Tumors

Researchers at Karolinska Institutet and SciLifeLab in Sweden have combined artificial intelligence (AI) techniques used in satellite imaging and community ecology to interpret large amounts of data from tumour tissue. The method, presented in the journal Nature Communications, could contribute to more personalised treatment of cancer patients.

While recent advances in tumour imaging provide a great insight into the microscopic world of tumours, the challenge is to interpret the huge amount of data generated. With hundreds of molecules being measured simultaneously in tens or hundreds of thousands of cells, it has become difficult for researchers to know what molecules and cells to focus on.

AI methods can in principle help researchers analyse this avalanche of data and determine what to focus on. However, traditional AI such as deep neural networks often performs tasks without providing clear explanations that are understandable to humans. Details of how the process works are hidden or difficult to access in a so-called black box. The research team at Karolinska Institutet and SciLifeLab recognised the limitations of such methods and sought inspiration from other fields. They identified well-established analysis techniques in satellite imaging and ecology dating back to the 2000s and 1950s, respectively.

Similar to interpreting satellite images

New AI methods are continuously developed to interpret data from satellite images, for example to automatically identify cities, lakes, forests and deserts within large satellite images. In ecology, advanced techniques are used to reveal how species of plants, animals and micro-organisms cohabit as communities within a given geographical area.

"We realised that the interpretation of tumour images is similar to the interpretation of satellite images and that the relationships between cells in a tissue are similar to the relationships between species in ecology," explains Jean Hausser, senior researcher at the Department of Cell and Molecular Biology, Karolinska Institutet, who led the research. "By combining techniques used in satellite imaging and ecology and adapting them for the analysis of tumour tissue, we have now been able to turn complex data into new insights into how cancer works."

Tailor cancer treatments

The next step is to apply the new method in clinical trials. The researchers are collaborating with a major cancer hospital in Lyon, France, to seek answers to why only some patients respond to cancer immunotherapy. In another collaboration with the Mayo Clinic in the US, they are investigating why some breast cancer patients don’t need chemotherapy.

"With our new method, we can reveal important details in tumour tissue that can determine whether a cancer treatment works or not. The long-term goal is to be able to tailor cancer treatments to individual needs and avoid unnecessary side effects," says Jean Hausser.

The research was mainly funded by the Swedish Cancer Society, the Swedish Research Council and SciLifeLab. There are no reported conflicts of interest.

El Marrahi A, Lipreri F, Kang Z, Gsell L, Eroglu A, Alber D, Hausser J.
NIPMAP: niche-phenotype mapping of multiplex histology data by community ecology.
Nat Commun. 2023 Nov 7;14(1):7182. doi: 10.1038/s41467-023-42878-z

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...